Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndromes; Non-Hodgkin Lymphoma; Hodgkin Disease Interventions: Procedure: Stem cell transplantation; Drug: Itacitinib; Other: Functional Assessment of Cancer Therapy-Bone Marrow Transplant; Other: Human Activity Profile Sponsors: Washington University School of Medicine; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Marrow Transplant | Cancer | Cancer & Oncology | Cancer Therapy | Leukemia | Lymphoma | Research | Study | Transplants